ArticleCureus2024
Sebaceoma of the Eyelid Originating in a Meibomian Gland: A Rare Case and Literature Review.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sebaceoma is an infrequently diagnosed benign neoplasm with sebaceous differentiation. This tumor usually presents in areas rich in sebaceous glands, such as the face, scalp, or trunk. The periocular tissues are an exceptionally uncommon site for sebaceoma, making sebaceoma of the eyelid an extremely rare entity. To our knowledge, only five cases of sebaceoma of the eyelid have been reported, with only one of these five originating in a Meibomian gland. Due to its rarity and the wide spectrum of skin lesions, sebaceoma is considered a diagnostically challenging lesion. When the diagnosis is uncertain, a biopsy followed by histopathological analysis should be performed to carefully differentiate sebaceoma from other eyelid tumors. Histopathologically, sebaceoma displays a wide range of patterns, from those seen in sebaceous adenoma to features that can be difficult to distinguish from sebaceous gland carcinoma. We report the case of a 64-year-old Caucasian male presenting with sebaceoma of a Meibomian gland of the left lower eyelid margin. The diagnosis of sebaceoma was made based on a routine histopathological examination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.